Q301--Long -Term Specialized Reference Laboratory for Measurable Residual Disease (MRD) detection in hematologic malignancies - Base Plus 4 9/1/26-8/31/31

Location: Federal
Posted: Jul 2, 2026
Due: Jul 10, 2026
Agency: VETERANS AFFAIRS, DEPARTMENT OF
Type of Government: Federal
Category:
  • Q - Medical Services
Solicitation No: 36C26026Q0807
Publication URL: To access bid details, please log in.
Follow
Q301--Long -Term Specialized Reference Laboratory for Measurable Residual Disease (MRD) detection in hematologic malignancies - Base Plus 4 9/1/26-8/31/31
Active
Contract Opportunity
Notice ID
36C26026Q0807
Related Notice
Department/Ind. Agency
VETERANS AFFAIRS, DEPARTMENT OF
Sub-tier
VETERANS AFFAIRS, DEPARTMENT OF
Office
260-NETWORK CONTRACT OFFICE 20 (36C260)
Looking for contract opportunity help?

APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.

APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.

The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).

General Information
  • Contract Opportunity Type: Sources Sought (Original)
  • Original Published Date: Jul 02, 2026 11:49 am PDT
  • Original Response Date: Jul 10, 2026 10:00 am PDT
  • Inactive Policy: Manual
  • Original Inactive Date: Jul 25, 2026
  • Initiative:
    • None
Classification
  • Original Set Aside:
  • Product Service Code: Q301 - REFERENCE LABORATORY TESTING
  • NAICS Code:
    • 621511 - Medical Laboratories
  • Place of Performance:
    Portland VAMC 3710 NW US Veterans Hospital Road Portland , 97239
Description
The VA Portland Healthcare System (VHAPORHCS) Pathology & Laboratory Medicine Service Department requires continued access to specialized testing for Measurable Residual Disease (MRD) detection in hematologic malignancies. MRD is a powerful diagnostic and prognostic tool that quantifies the presence of residual cancer cells during and after treatment in patients with multiple myeloma, B-cell acute lymphoblastic leukemia (B-ALL), and chronic lymphocytic leukemia (CLL).
Attachments/Links
Contact Information
Contracting Office Address
  • 1601 E Fourth Plain Blvd Bldg 17 Suite B428
  • VANCOUVER , WA 98661
  • USA
Primary Point of Contact
Secondary Point of Contact


History

Related Document

Jul 2, 2026[Solicitation (Original)] Q301--Long -Term Specialized Reference Laboratory for Measurable Residual Disease (MRD) detection in hematologic malignancies - Base Plus 4 9/1/26-8/31/31
Daily notification on new contract opportunities

With GovernmentContracts, you can:

  • Find more opportunities and win more business
  • Receive daily alerts for all new bid opportunities
  • Get contract opportunities matched to your business
ONE WEEK FREE TRIAL

See also

Health Care Delivery System (...

...Response Date: Aug 30, 2026 03:00 pm EDT Inactive Policy: Manual Original Inactive ...

DEPT OF DEFENSE

Bid Due: 8/30/2026

R499--Confined Space Inventor...

...Date Offers Due: Jul 20, 2026 04:30 pm EDT Inactive Policy: Manual Original ...

VETERANS AFFAIRS, DEPARTMENT OF

Bid Due: 7/20/2026

U099--SOLE SOURCE: National Q...

...Original Response Date: Jul 30, 2026 09:00 am EDT Inactive Policy: Manual Original ...

VETERANS AFFAIRS, DEPARTMENT OF

Bid Due: 7/30/2026

Multiscale Reasoning For Huma...

...Response Date: Aug 10, 2026 05:00 pm EDT Inactive Policy: Manual Original Inactive ...

DEPT OF DEFENSE

Bid Due: 8/10/2026

* Disclaimer: Information regarding bids, requests for proposals (RFPs), or requests for qualifications (RFQs) is provided on this website only for convenience and does not constitute official public notice. Persons wishing to respond to or inquire about bids, RFPs, or RFQs should contact the appropriate government department.
© 2000-2026 GovernmentContracts. All rights reserved.